0000950170-25-092273.txt : 20250701 0000950170-25-092273.hdr.sgml : 20250701 20250701163224 ACCESSION NUMBER: 0000950170-25-092273 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250627 FILED AS OF DATE: 20250701 DATE AS OF CHANGE: 20250701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Stephen Basil CENTRAL INDEX KEY: 0002027962 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 251096876 MAIL ADDRESS: STREET 1: 2525 SMITH STREET CITY: SCOTCH PLAINS STATE: NJ ZIP: 07076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Climb Bio, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 WILLIAM STREET STREET 2: SUITE 145 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 BUSINESS PHONE: 1-866-857-2596 MAIL ADDRESS: STREET 1: 20 WILLIAM STREET STREET 2: SUITE 145 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 FORMER COMPANY: FORMER CONFORMED NAME: Eliem Therapeutics, Inc. DATE OF NAME CHANGE: 20190219 4 1 ownership.xml 4 X0508 4 2025-06-27 0001768446 Climb Bio, Inc. CLYM 0002027962 Thomas Stephen Basil C/O CLIMB BIO, INC. 20 WILLIAM STREET, SUITE 145 WELLESLEY HILLS MA 02481 true false false false false Common Stock 2025-06-27 4 M false 25094 A 204282 D Restricted Stock Units 2025-06-27 4 M false 25094 0 D Common Stock 25094 0 D Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs were granted on June 27, 2024 and vested as to 50% of the shares on January 1, 2025, vested as to 25% of the shares on March 27, 2025 and vested as to the remaining 25% of the shares on June 27, 2025, subject to the Reporting Person's continued service. Exhibit Index: 24.1 - Power of Attorney /s/ Chandra Adams, as Attorney-in-Fact 2025-07-01 EX-24.1 2 ck0001768446-ex24_1.htm EX-24.1 EX-24.1

 

 

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes and appoints each of Chandra Adams, Aoife Brennan and Cindy Driscoll of Climb Bio, Inc., signing individually, the undersigned’s true and lawful attorneys-in fact and agents to:

(1)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation thereunder;

 

(2)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the SEC Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

(3)
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such Forms with the SEC and any stock exchange, self-regulatory association or any other authority; and

 

(4)
take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by the attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney-in-fact may approve in the attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is Climb Bio, Inc. (the “Company”) assuming) any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below.

 

Dated:

June 27, 2025

 

 

 

 

 

 

By:

/s/ Stephen Thomas, Ph.D.

 

Stephen Thomas

 

Signature

 

Printed Name